Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver
disease worldwide. Although NAFLD is tightly linked to obesity and type 2 diabetes, this liver …

Nonalcoholic fatty liver disease (NAFLD) is increasingly prevalent worldwide and becoming
a major cause of liver disease-related morbidity and mortality. The presence of liver fibrosis …

Conclusions: This consensus-driven multidisciplinary fatty liver disease action agenda
developed by care providers, clinical researchers, and public health and policy experts …

Hepatocellular carcinoma (HCC) mortality remains high primarily due to late diagnosis as a
consequence of failed early detection. Professional societies recommend semi‐annual HCC …

Non-alcoholic fatty liver disease (NAFLD) is becoming the most common liver disease
worldwide, and its burden is expected to increase due to the growing epidemic of obesity …

Background Patients with nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes
(T2D) or other components of metabolic syndrome are at high risk for disease progression …

Objective We intend to look at the link between remnant cholesterol (RC) and nonalcoholic
fatty liver disease (NAFLD). We hypothesise that there may be a positive and nonlinear …

Multiple animals and in vitro studies have demonstrated that perfluoroalkyl and
polyfluoroalkyl substances (PFASs) exposure causes liver damage associated with fat …

Liver fibrosis is critical for liver-related outcomes and mortality in chronic liver disease,
irrespective of etiology, including nonalcoholic fatty liver disease (NAFLD). NAFLD has been …

Background & Aims Nonalcoholic fatty liver disease (NAFLD)-related fibrosis is heritable, but
it is unclear how family history may be used to identify first-degree relatives with advanced …